| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1038760800 |
| P356 | DOI | 10.2165/00003495-198836030-00005 |
| P698 | PubMed publication ID | 3056693 |
| P2093 | author name string | M Arnold | |
| P Brooks | |||
| L Schrieber | |||
| P2860 | cites work | The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis | Q69586065 |
| Cyclophosphamide-Induced Ovarian Failure | Q69612087 | ||
| Cyclosporin A treatment of refractory rheumatoid arthritis | Q69743710 | ||
| Methotrexate and the liver | Q69788215 | ||
| Cyclosporin in autoimmune disease | Q69859604 | ||
| Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis | Q69876135 | ||
| Efficacy of low-dose methotrexate in rheumatoid arthritis | Q69884411 | ||
| Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial | Q69899068 | ||
| Cyclosporine improves psoriasis in a double-blind study | Q70154695 | ||
| Low dose adrenocorticosteroids in the management of elderly patients with rheumatoid arthritis: Selected examples and summary of efficacy in the long-term treatment of 97 patients | Q70272465 | ||
| Low dose prednisone therapy in rheumatoid arthritis: a double blind study | Q70302183 | ||
| A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis | Q70409082 | ||
| Side effects of systemic cyclosporine in patients not undergoing transplantation | Q70636109 | ||
| Effect and mode of action of chlorambucil in rheumatoid disease. Value of the lymphoblastic transformation test | Q70685119 | ||
| Methotrexate levels, a guide to therapy? | Q71226511 | ||
| Poor long-term results from low-dose methotrexate therapy in rheumatoid arthritis | Q71347998 | ||
| Pulse therapy in rheumatoid arthritis | Q71426942 | ||
| Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial | Q71426991 | ||
| Survivorship and Death in Rheumatoid Arthritis | Q71439618 | ||
| The effects and side effects of cyclosporine: relationship to drug pharmacokinetics | Q71482447 | ||
| Long-term cyclophosphamide therapy in rheumatoid arthritis | Q72046682 | ||
| Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis | Q72135348 | ||
| Acute monoblastic leukaemia in child receiving chlorambucil for juvenile rheumatoid arthritis | Q72421387 | ||
| Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis | Q72574923 | ||
| Long-term study of management of rheumatoid arthritis | Q72576157 | ||
| Length of life and cause of death in rheumatoid arthritis | Q73268669 | ||
| A COMPARISON of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis; a second report by the Joint Committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, A.C.T.H., and other therap | Q73789342 | ||
| Intravenous administration of nitrogen mustard alone and with corticotropin for rheumatoid arthritis | Q74489376 | ||
| EMPIRE Rheumatism Council: multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results of three years' treatment | Q74633544 | ||
| Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis | Q75626103 | ||
| Treatment of rheumatoid arthritis with nitrogen mustard; preliminary report | Q75831854 | ||
| METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS | Q76860899 | ||
| Effects of cancer chemotherapeutic agents on the human fetus | Q79268547 | ||
| AN AQUEOUS EXTRACT OF THE SUPRARENAL CORTEX WHICH MAINTAINS THE LIFE OF BILATERALLY ADRENALECTOMIZED CATS | Q81019336 | ||
| Liver biopsy in methotrexate-treated psoriatics-a re-evalution | Q28317794 | ||
| The Incidence Of Bladder Cancer after Cyclophosphamide Therapy | Q28327318 | ||
| Controlled trial of cyclophosphamide in rheumatoid arthritis | Q28329020 | ||
| Chlorambucil therapy in rheumatoid arthritis: clinical experience in 28 patients and literature review | Q33457485 | ||
| Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study | Q33459089 | ||
| Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold | Q33477682 | ||
| Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis | Q33552918 | ||
| Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo | Q33553024 | ||
| Long-term azathioprine in rheumatoid arthritis: a double-blind study | Q33553329 | ||
| Conversion from daily to alternate daily corticosteroids in rheumatoid arthritis | Q33553483 | ||
| The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up | Q33554543 | ||
| Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study | Q33556920 | ||
| Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study | Q33556926 | ||
| Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids | Q33557071 | ||
| Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjögren's syndrome | Q33557218 | ||
| Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis | Q33557392 | ||
| Long-term effects of azathioprine in rheumatoid arthritis | Q33625350 | ||
| Short term cyclosporin A treatment of Behçet's disease | Q33645611 | ||
| Clearance of psoriasis with low dose cyclosporin | Q34288649 | ||
| Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy | Q34330594 | ||
| The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis | Q34586344 | ||
| Alterations in prednisolone disposition as a result of time of administration, gender and dose | Q34621156 | ||
| Secretion of methotrexate into human milk | Q34701260 | ||
| Successful pregnancy in a renal transplant recipient taking cyclosporin A | Q34990751 | ||
| Chlorambucil induced chromosome damage in juvenile chronic arthritis | Q35602563 | ||
| Immunosuppressive drugs in the management of malignant and severe rheumatoid arthritis | Q35860242 | ||
| Cyclophosphamide Therapy for Rheumatoid Arthritis | Q66895137 | ||
| Chlorambucil in rheumatoid polyarthritis | Q67256582 | ||
| Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial | Q67481306 | ||
| Methotrexate-induced pneumonitis | Q67794570 | ||
| Comparison of methylprednisolone (1 g i.v.) with prednisolone (1 g orally) in rheumatoid arthritis: a pharmacokinetic and clinical study | Q68330764 | ||
| Azathioprine in rheumatoid arthritis. A double-blind, cross over study | Q68509181 | ||
| Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs | Q68859513 | ||
| Side effects of cyclosporin A treatment in patients with rheumatoid arthritis | Q68896511 | ||
| Successful pregnancy in a renal transplant recipient taking cyclosporin A | Q68948781 | ||
| Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial | Q68956193 | ||
| Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates | Q68970520 | ||
| Double-blind study of cyclophosphamide in rheumatoid arthritis | Q69275733 | ||
| Development of reticulum cell sarcoma during cyclophosphamide therapy | Q69315490 | ||
| Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study | Q69462785 | ||
| Survival, prognosis, and causes of death in rheumatoid arthritis | Q69539302 | ||
| Pharmacokinetics of methotrexate | Q69559055 | ||
| Nonassociation of Adrenocorticosteroid Therapy and Peptic Ulcer | Q36776305 | ||
| Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis | Q39118482 | ||
| Disease-modifying agents and immunosuppressive drugs in the elderly | Q39449294 | ||
| Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety | Q39664793 | ||
| Clinical Pharmacokinetics of Prednisone and Prednisolone | Q39798747 | ||
| Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate | Q39804413 | ||
| Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis | Q39841817 | ||
| Toxicity of low dose methotrexate in rheumatoid arthritis. | Q39841838 | ||
| Glucocorticoids and the gastrointestinal tract: current status | Q39892587 | ||
| Cytotoxic drug-induced pulmonary disease: update 1980. | Q40097531 | ||
| Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature | Q40154578 | ||
| Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases | Q40154586 | ||
| Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis? | Q40158596 | ||
| Cyclosporine: a new immunosuppressive agent for organ transplantation | Q40188861 | ||
| Combined disease-modifying chemotherapy for intractable rheumatoid arthritis. | Q40196439 | ||
| Methotrexate: its use in the rheumatic diseases | Q40202658 | ||
| Local corticosteroid injection treatment in rheumatic disorders | Q40260864 | ||
| Gonadal dysfunction in patients receiving chemotherapy for cancer | Q40286981 | ||
| A combined clinical and immunological assessment of four cyclophosphamide regimes in rheumatoid arthritis | Q41074370 | ||
| Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine | Q41117952 | ||
| Corticosteroids in rheumatoid arthritis: is a trial of their 'disease modifying' potential feasible? | Q41151747 | ||
| Severe dermatomyositis treated with cyclosporin A. | Q41177422 | ||
| Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine | Q41246135 | ||
| Low dose pulse methotrexate therapy in rheumatoid arthritis. | Q41480440 | ||
| Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation | Q41644647 | ||
| Risk of acute leukosis after treatment of chronic inflammatory rheumatism and connective tissue inflammation with immunosuppressive cytotoxic drugs. Results of a retrospective study of 2,006 treated patients | Q41759997 | ||
| Long-term outcome of treating rheumatoid arthritis: results after 20 years | Q41913707 | ||
| Death Rate and Causes of Death in Patients with Rheumatoid Arthritis | Q42139986 | ||
| Toxicity of methotrexate in rheumatoid arthritis | Q42217990 | ||
| Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy | Q42231745 | ||
| Bladder Toxicity With Chronic Oral Cyclophosphamide Therapy in Nonmalignant Disease | Q42234695 | ||
| Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment | Q42434922 | ||
| Renal cadaver transplantation followed by successful pregnancies | Q44170991 | ||
| Effectiveness of cyclosporin therapy for Behçet's disease | Q44422787 | ||
| Complications and sequelae of immunosuppressive therapy of rheumatoid arthritis | Q45046328 | ||
| Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis | Q45208263 | ||
| Rheumatoid arthritis treated with chlorambucil: a five-year follow-up | Q46472645 | ||
| Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation | Q47990976 | ||
| Corticosteroid treatment in rheumatoid arthritis | Q48491330 | ||
| Azathioprine in Rheumatoid Arthritis | Q49164656 | ||
| Methotrexate therapy in rheumatoid arthritis: 15 years experience | Q50587354 | ||
| Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. | Q53021508 | ||
| Azathioprine and cyclophosphamide as slow-acting drugs for rheumatoid arthritis. | Q53556652 | ||
| Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis. | Q53595238 | ||
| Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. | Q53793714 | ||
| A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. | Q53809366 | ||
| Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis. | Q53928851 | ||
| Multiple late complications of therapy with cyclophosphamide, including ovarian destruction | Q53995512 | ||
| Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis | Q54061374 | ||
| An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. | Q54139601 | ||
| Cyclosporin A in rheumatoid arthritis: preliminary clinical results of an open trial. | Q54140592 | ||
| Effects of methotrexate on the liver in psoriasis. | Q54220507 | ||
| Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis. | Q55384602 | ||
| Malignancy following treatment of rheumatoid arthritis with cyclophosphamide | Q59647405 | ||
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 340-363 | |
| P577 | publication date | 1988-09-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis | |
| P478 | volume | 36 |
| Q72113329 | Acute myelogenous leukemia in a rheumatoid arthritis patient under cyclosporine a therapy |
| Q42485895 | Basal and stimulated elastolytic activity of blood monocytes is increased in glucocorticoid-treated giant cell arteritis |
| Q37799060 | Disease-modifying antirheumatic and immunoregulatory agents |
| Q39510485 | Pain of the joint of inflammatory diseases pathobiochemistry and pharmacology |
| Q40816610 | Rheumatoid arthritis in the aged. Incidence and optimal management |
| Q37941563 | Utilization patterns of non-steroidal anti-inflammatory drugs in an open Dutch population |
Search more.